Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v1-EN
Language French English
Date Updated 2022-12-12 2022-11-24
Drug Identification Number 02381842 02381842
Brand name TAMIFLU TAMIFLU
Common or Proper name TAMIFLU TAMIFLU
Company Name HOFFMANN-LA ROCHE LIMITED HOFFMANN-LA ROCHE LIMITED
Ingredients OSELTAMIVIR OSELTAMIVIR
Strength(s) 6MG 6MG
Dosage form(s) POWDER FOR SUSPENSION POWDER FOR SUSPENSION
Route of administration ORAL ORAL ORAL ORAL
Packaging size 6MG/ML 6MG/ML
ATC code J05AH J05AH
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2022-11-24 2022-11-24
Estimated end date 2022-12-16 2022-12-16
Actual end date 2022-12-09
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Please note Tamiflu 30mg and Tamiflu 45mg are currently available for order with no supply disruptions. Please note Tamiflu 30mg and Tamiflu 45mg are currently available for order with no supply disruptions.
Health Canada comments